Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMDC transplantation for fecal incontinence
2013-004672-35Phase 2Unknown
- Sponsor
- Cook MyoSite
- Start
- Mar 2014
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of AMDC-USR in fecal incontinence (FI), sponsored by Cook MyoSite. Primary endpoint: Incidence of treatment-related serious adverse events and protocol-defined treatment- or procedure-related adverse events. Status: unknown.
02
Drugs
AMDC-USR
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on 2013-004672-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004672-35.